Antiviral activity and platelet-mediated mechanisms. TPO receptor agonists increase megakaryocyte viability and proliferation, leading to an increase in platelet counts. Platelets activated by virus endocytose virions and release granules, ultimately exerting their antiviral activity by stimulating immune cells and activating the complement system.